Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2,4 Dichloroquinazoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102584721B reveals a mild triphosgene-based route for 2,4-dichloroquinazoline derivatives, offering significant cost reduction in API manufacturing and improved safety.